Caloric restriction preserves memory and reduces anxiety of aging mice with early enhancement of neurovascular functions

Aging

Volumn 8, Issue 11, 2016, Pages 2814-2826

  Parikh, Ishita ^a   Guo, Janet ^a   Chuang, Kai Hsiang ^b   Zhong, Yu ^a   Rempe, Ralf G ^c   Hoffman, Jared D ^a   Armstrong, Rachel ^a   Bauer, Björn ^c   Hartz, Anika M S ^a   Lin, Ai Ling ^a,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Anxiety; Blood brain barrier; Caloric restriction; Cerebral blood flow; Cognition; Magnetic resonance imaging (MRI); Mammalian target of rapamcyin (mTOR)

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

AGING; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; BLOOD BRAIN BARRIER; BRAIN CIRCULATION; CALORIC RESTRICTION; COGNITION; FRONTAL LOBE; HIPPOCAMPUS; MALE; MEMORY; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; CALORIC RESTRICTION; CEREBROVASCULAR CIRCULATION; COGNITION; FRONTAL LOBE; HIPPOCAMPUS; MALE; MEMORY; MICE; NITRIC OXIDE SYNTHASE TYPE III; SIGNAL TRANSDUCTION;

EID: 85002158057     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.101094     Document Type: Article

References (71)

1. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011; 12:723-38.
2. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004; 5:347-60. doi: 10.1038/nrn1387.
3. Bangen KJ, Beiser A, Delano-Wood L, Nation DA, Lamar M, Libon DJ, Bondi MW, Seshadri S, Wolf PA, Au R. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline. J Stroke Cerebrovasc Dis. 2013; 22:1361-69. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.013.
4. Ebmeier KP, Cavanagh JT, Moffoot AP, Glabus MF, O'Carroll RE, Goodwin GM. Cerebral perfusion correlates of depressed mood. Br J Psychiatry. 1997; 170:77-81. doi: 10.1192/bjp.170.1.77.
5. Gur RC, Gur RE, Resnick SM, Skolnick BE, Alavi A, Reivich M. The effect of anxiety on cortical cerebral blood flow and metabolism. J Cereb Blood Flow Metab. 1987; 7:173-77. doi: 10.1038/jcbfm.1987.40.
6. Park J, Moghaddam B. Impact of anxiety on prefrontal cortex encoding of cognitive flexibility. Neuroscience. 2016; Epub ahead of print.
7. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012; 485:512-16.
8. Martin AJ, Friston KJ, Colebatch JG, Frackowiak RS. Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab. 1991; 11:684-89. doi: 10.1038/jcbfm.1991.121.
9. Thambisetty M, Beason-Held L, An Y, Kraut MA, Resnick SM. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol. 2010; 67:93-98. doi: 10.1001/archneurol.2009.913.
10. Nagata K, Buchan RJ, Yokoyama E, Kondoh Y, Sato M, Terashi H, Satoh Y, Watahiki Y, Senova M, Hirata Y, Hatazawa J. Misery perfusion with preserved vascular reactivity in Alzheimer's disease. Ann N Y Acad Sci. 1997; 826:272-81. doi: 10.1111/j.1749-6632.1997.tb48479.x.
11. Bentourkia M, Bol A, Ivanoiu A, Labar D, Sibomana M, Coppens A, Michel C, Cosnard G, De Volder AG. Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging. J Neurol Sci. 2000; 181:19-28. doi: 10.1016/S0022-510X(00)00396-8.
12. Montagne A, Nation DA, Pa J, Sweeney MD, Toga AW, Zlokovic BV. Brain imaging of neurovascular dysfunction in Alzheimer's disease. Acta Neuropathol. 2016; 131:687-707. doi: 10.1007/s00401-016-1570-0.
13. Choi JS, Choi KM, Lee CK. Caloric restriction improves efficiency and capacity of the mitochondrial electron transport chain in Saccharomyces cerevisiae. Biochem Biophys Res Commun. 2011; 409:308-14. doi: 10.1016/j.bbrc.2011.05.008.
14. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325:201-04. doi: 10.1126/science.1173635.
15. Rahat O, Maoz N, Cohen HY. Multiple pathways regulating the calorie restriction response in yeast. J Gerontol A Biol Sci Med Sci. 2011; 66:163-69. doi: 10.1093/gerona/glq165.
16. Gillette-Guyonnet S, Vellas B. Caloric restriction and brain function. Curr Opin Clin Nutr Metab Care. 2008; 11:686-92. doi: 10.1097/MCO.0b013e328313968f.
17. Guo J, Bakshi V, Lin AL. Early Shifts of Brain Metabolism by Caloric Restriction Preserve White Matter Integrity and Long-Term Memory in Aging Mice. Front Aging Neurosci. 2015; 7:213. doi: 10.3389/fnagi.2015.00213.
18. Lin AL, Coman D, Jiang L, Rothman DL, Hyder F. Caloric restriction impedes age-related decline of mitochondrial function and neuronal activity. J Cereb Blood Flow Metab. 2014; 34:1440-43. doi: 10.1038/jcbfm.2014.114.
19. Fontán-Lozano A, López-Lluch G, Delgado-García JM, Navas P, Carrión AM. Molecular bases of caloric restriction regulation of neuronal synaptic plasticity. Mol Neurobiol. 2008; 38:167-77. doi: 10.1007/s12035-008-8040-1.
20. Mattson MP. The impact of dietary energy intake on cognitive aging. Front Aging Neurosci. 2010; 2:5.
21. Valdez G, Tapia JC, Kang H, Clemenson GD Jr, Gage FH, Lichtman JW, Sanes JR. Attenuation of agerelated changes in mouse neuromuscular synapses by caloric restriction and exercise. Proc Natl Acad Sci USA. 2010; 107:14863-68. doi: 10.1073/pnas.1002220107.
22. Witte AV, Fobker M, Gellner R, Knecht S, Flöel A. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci USA. 2009; 106:1255-60. doi: 10.1073/pnas.0808587106.
23. Mouton PR, Chachich ME, Quigley C, Spangler E, Ingram DK. Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice. Neurosci Lett. 2009; 464:184-87. doi: 10.1016/j.neulet.2009.08.038.
24. Schafer MJ, Alldred MJ, Lee SH, Calhoun ME, Petkova E, Mathews PM, Ginsberg SD. Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice. Neurobiol Aging. 2015; 36:1293-302. doi: 10.1016/j.neurobiolaging.2014.10.043.
25. Lin AL, Zhang W, Gao X, Watts L. Caloric restriction increases ketone bodies metabolism and preserves blood flow in aging brain. Neurobiol Aging. 2015; 36:2296-303. doi: 10.1016/j.neurobiolaging.2015.03.012.
26. Hartz AM, Miller DS, Bauer B. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol Pharmacol. 2010; 77:715-23. doi: 10.1124/mol.109.061754.
27. Hartz AM, Zhong Y, Wolf A, LeVine H 3rd, Miller DS, Bauer B. Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. J Neurosci. 2016; 36:1930-41. doi: 10.1523/JNEUROSCI.0350-15.2016.
28. Blagosklonny MV. Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle. 2010; 9:683-88. doi: 10.4161/cc.9.4.10766.
29. Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991; 253:905-09. doi: 10.1126/science.1715094.
30. Lin AL, Zheng W, Halloran JJ, Burbank RR, Hussong SA, Hart MJ, Javors M, Shih YY, Muir E, Solano Fonseca R, Strong R, Richardson AG, Lechleiter JD, et al. Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease. J Cereb Blood Flow Metab. 2013; 33:1412-21. doi: 10.1038/jcbfm.2013.82.
31. Cheng C, Tempel D, Oostlander A, Helderman F, Gijsen F, Wentzel J, van Haperen R, Haitsma DB, Serruys PW, van der Steen AF, de Crom R, Krams R. Rapamycin modulates the eNOS vs. shear stress relationship. Cardiovasc Res. 2008; 78:123-29. doi: 10.1093/cvr/cvm103.
32. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE, Diamond DM. Progressive, agerelated behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 2001; 891:42-53. doi: 10.1016/S0006-8993(00)03186-3.
33. Sood A, Warren Beach J, Webster SJ, Terry AV, Buccafusco JJ. The effects of JWB1-84-1 on memoryrelated task performance by amyloid Abeta transgenic mice and by young and aged monkeys. Neuropharmacology. 2007; 53:588-600. doi: 10.1016/j.neuropharm.2007.06.028.
34. Bachstetter AD, Webster SJ, Tu T, Goulding DS, Haiech J, Watterson DM, Van Eldik LJ. Generation and behavior characterization of CaMKIIβ knockout mice. PLoS One. 2014; 9:e105191. doi: 10.1371/journal.pone.0105191.
35. Lin AL, Jahrling JB, Zhang W, DeRosa N, Bakshi V, Romero P, Galvan V, Richardson A. Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with presymptomatic Alzheimer's disease. J Cereb Blood Flow Metab. 20150271678X15621575.
36. Son S, Stevens MM, Chao HX, Thoreen C, Hosios AM, Schweitzer LD, Weng Y, Wood K, Sabatini D, Vander Heiden MG, Manalis S. Cooperative nutrient accumulation sustains growth of mammalian cells. Sci Rep. 2015; 5:17401. doi: 10.1038/srep17401.
37. Mattson MP, Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem. 2005; 16:129-37. doi: 10.1016/j.jnutbio.2004.12.007.
38. Gómez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci. 2008; 9:568-78. doi: 10.1038/nrn2421.
39. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013; 339:211-14. doi: 10.1126/science.1227166.
40. Katewa SD, Demontis F, Kolipinski M, Hubbard A, Gill MS, Perrimon N, Melov S, Kapahi P. Intramyocellular fatty-acid metabolism plays a critical role in mediating responses to dietary restriction in Drosophila melanogaster. Cell Metab. 2012; 16:97-103. doi: 10.1016/j.cmet.2012.06.005.
41. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol. 2004; 55:576-80. doi: 10.1002/ana.20062.
42. Hasselbalch SG, Madsen PL, Hageman LP, Olsen KS, Justesen N, Holm S, Paulson OB. Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol. 1996; 270:E746-51.
43. Linde R, Hasselbalch SG, Topp S, Paulson OB, Madsen PL. Global cerebral blood flow and metabolism during acute hyperketonemia in the awake and anesthetized rat. J Cereb Blood Flow Metab. 2006; 26:170-80. doi: 10.1038/sj.jcbfm.9600177.
44. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids. 2004; 70:309-19. doi: 10.1016/j.plefa.2003.09.007.
45. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science. 1988; 241:462-64. doi: 10.1126/science.3260686.
46. Chowdhury GM, Jiang L, Rothman DL, Behar KL. The contribution of ketone bodies to basal and activitydependent neuronal oxidation in vivo. J Cereb Blood Flow Metab. 2014; 34:1233-42. doi: 10.1038/jcbfm.2014.77.
47. Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME. Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci USA. 2010; 107:17757-62. doi: 10.1073/pnas.1010459107.
48. Palmer CS, Ostrowski M, Balderson B, Christian N, Crowe SM. Glucose metabolism regulates T cell activation, differentiation, and functions. Front Immunol. 2015; 6:1. doi: 10.3389/fimmu.2015.00001.
49. Vlassenko AG, Raichle ME. Brain aerobic glycolysis functions and Alzheimer's disease. Clin Transl Imaging. 2015; 3:27-37. doi: 10.1007/s40336-014-0094-7.
50. Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, Mach RH, Morris JC, Raichle ME, Mintun MA. Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition. Proc Natl Acad Sci USA. 2010; 107:17763-67. doi: 10.1073/pnas.1010461107.
51. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 2005; 48:913-22. doi: 10.1016/j.neuron.2005.10.028.
52. Whalley LJ, Staff RT, Fox HC, Murray AD. Cerebral correlates of cognitive reserve. Psychiatry Res. 2016; 247:65-70. doi: 10.1016/j.pscychresns.2015.10.012.
53. Arenaza-Urquijo EM, Wirth M, Chételat G. Cognitive reserve and lifestyle: moving towards preclinical Alzheimer's disease. Front Aging Neurosci. 2015; 7:134. doi: 10.3389/fnagi.2015.00134.
54. Willette AA, Coe CL, Colman RJ, Bendlin BB, Kastman EK, Field AS, Alexander AL, Allison DB, Weindruch RH, Johnson SC. Calorie restriction reduces psychological stress reactivity and its association with brain volume and microstructure in aged rhesus monkeys. Psychoneuroendocrinology. 2012; 37:903-16. doi: 10.1016/j.psyneuen.2011.10.006.
55. Halloran J, Hussong SA, Burbank R, Podlutskaya N, Fischer KE, Sloane LB, Austad SN, Strong R, Richardson A, Hart MJ, Galvan V. Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience. 2012; 223:102-13. doi: 10.1016/j.neuroscience.2012.06.054.
56. Tsai PT, Hull C, Chu Y, Greene-Colozzi E, Sadowski AR, Leech JM, Steinberg J, Crawley JN, Regehr WG, Sahin M. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature. 2012; 488:647-51. doi: 10.1038/nature11310.
57. Zhou M, Li W, Huang S, Song J, Kim JY, Tian X, Kang E, Sano Y, Liu C, Balaji J, Wu S, Zhou Y, Zhou Y, et al. mTOR Inhibition ameliorates cognitive and affective deficits caused by Disc1 knockdown in adult-born dentate granule neurons. Neuron. 2013; 77:647-54. doi: 10.1016/j.neuron.2012.12.033.
58. Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013; 493:338-45. doi: 10.1038/nature11861.
59. Bartels AL, Kortekaas R, Bart J, Willemsen AT, de Klerk OL, de Vries JJ, van Oostrom JC, Leenders KL. Bloodbrain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging. 2009; 30:1818-24. doi: 10.1016/j.neurobiolaging.2008.02.002.
60. Chiu C, Miller MC, Monahan R, Osgood DP, Stopa EG, Silverberg GD. P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations. Neurobiol Aging. 2015; 36:2475-82. doi: 10.1016/j.neurobiolaging.2015.05.020.
61. Pekcec A, Schneider EL, Baumgärtner W, Stein VM, Tipold A, Potschka H. Age-dependent decline of blood-brain barrier P-glycoprotein expression in the canine brain. Neurobiol Aging. 2011; 32:1477-85. doi: 10.1016/j.neurobiolaging.2009.08.014.
62. Liao CY, Rikke BA, Johnson TE, Diaz V, Nelson JF. Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening. Aging Cell. 2010; 9:92-95. doi: 10.1111/j.1474-9726.2009.00533.x.
63. Liao CY, Rikke BA, Johnson TE, Gelfond JA, Diaz V, Nelson JF. Fat maintenance is a predictor of the murine lifespan response to dietary restriction. Aging Cell. 2011; 10:629-39. doi: 10.1111/j.1474-9726.2011.00702.x.
64. Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M, Suez J, Mahdi JA, Matot E, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015; 163:1079-94. doi: 10.1016/j.cell.2015.11.001.
65. Sohal RS, Ferguson M, Sohal BH, Forster MJ. Life span extension in mice by food restriction depends on an energy imbalance. J Nutr. 2009; 139:533-39. doi: 10.3945/jn.108.100313.
66. Forster MJ, Morris P, Sohal RS. Genotype and age influence the effect of caloric intake on mortality in mice. FASEB J. 2003; 17:690-92.
67. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, and National Centre for the Replacement, Refinement and Reduction of Amimals in Research. Animal research: reporting in vivo experiments-the ARRIVE guidelines. J Cereb Blood Flow Metab. 2011; 31:991-93. doi: 10.1038/jcbfm.2010.220.
68. Hong X, To XV, Teh I, Soh JR, Chuang KH. Evaluation of EPI distortion correction methods for quantitative MRI of the brain at high magnetic field. Magn Reson Imaging. 2015; 33:1098-105. doi: 10.1016/j.mri.2015.06.010.
69. Alsop DC, Detre JA, Golay X, Gunther M, Hendrikse J, Hernandez-Garcia L, Lu H, Macintosh BJ, Parkes LM, Smits M, van Osch MJ, Wang DJ, Wong EC, et al. Recommended implementation of arterial spinlabeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med. 2014.
70. Hartz AM, Bauer B, Soldner EL, Wolf A, Boy S, Backhaus R, Mihaljevic I, Bogdahn U, Klünemann HH, Schuierer G, Schlachetzki F. Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke. 2012; 43:514-23. doi: 10.1161/STROKEAHA.111.627562.
71. Miller DS, Bauer B, Hartz AM. Modulation of Pglycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev. 2008; 60:196-209. doi: 10.1124/pr.107.07109.